ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or Other Jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification Number) | |
(Address of Principal Executive Office) |
(Zip Code) |
Title of each class |
Trading symbol |
Name of each exchange on which registered | ||
☒ | Accelerated filer ☐ | |
Non-accelerated filer ☐ |
Smaller reporting company | |
Emerging growth company |
INDEX |
||||||
Explanatory Note | ||||||
Part III | ||||||
Item 10. |
2 | |||||
Item 11. |
24 | |||||
Item 12. |
59 | |||||
Item 13. |
61 | |||||
Item 14. |
61 | |||||
Part IV | ||||||
Item 15. |
62 |
ITEM 10. |
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE |
Name DIRECTORS |
Position(s) Held With Investors Bancorp |
Age |
Director Since |
Current Term Expires |
||||||||||
Robert C. Albanese |
Director |
74 |
2013 |
2022 |
||||||||||
Domenick A. Cama |
Director, President and Chief Operating Officer |
65 |
2011 |
2022 |
||||||||||
James J. Garibaldi |
Director |
70 |
2012 |
2022 |
||||||||||
James H. Ward III |
Director |
73 |
2009 |
2022 |
||||||||||
Dennis M. Bone |
Lead Independent Director |
70 |
2013 |
2023 |
||||||||||
Doreen R. Byrnes |
Director |
72 |
2002 |
2023 |
||||||||||
William V. Cosgrove |
Director |
74 |
2011 |
2023 |
||||||||||
Kevin Cummings |
Chairman and Chief Executive Officer |
67 |
2008 |
2024 |
||||||||||
John E. Harmon, Sr. |
Director |
61 |
2021 |
2024 |
||||||||||
Michele N. Siekerka |
Director |
57 |
2013 |
2024 |
||||||||||
Paul N. Stathoulopoulos |
Director |
74 |
2018 |
2024 |
||||||||||
Kim Wales |
Director |
52 |
2021 |
2024 |
Robert C. Albanese The Nominating and Corporate Governance Committee considers Mr. Albanese’s extensive regulatory experience with particular expertise in financial analysis, enterprise risk analysis and audit to be assets to the Board of Directors. | ||
Domenick A. Cama Mr. Cama has extensive knowledge of the banking industry and local markets served by Investors Bank. The Nominating and Corporate Governance Committee considers Mr. Cama’s experience, leadership, financial expertise and strong economics background to be unique assets for the Board of Directors. | ||
James J. Garibaldi Mr. Garibaldi’s extensive real estate experience and knowledge of the local real estate market bring valuable expertise to the Board of Directors. The Nominating and Corporate Governance Committee considers Mr. Garibaldi’s leadership skills and real estate knowledge to be assets to the Board of Directors. |
James H. Ward III Mr. Ward brings a wide range of management experience and business knowledge that provides a valuable resource to the Board of Directors. These skills and experience combined with the unique perspective Mr. Ward brings from his background as an entrepreneur provide skills and experience which the Nominating and Corporate Governance Committee considers to be valuable assets for the Board of Directors. | ||
Dennis M. Bone The Nominating and Corporate Governance Committee believes that Mr. Bone’s experience, which brings a broader corporate perspective, as well as his extensive community involvement, to be assets to the Board of Directors. | ||
Doreen R. Byrnes Ms. Byrnes has extensive experience with executive recruitment, retention and compensation as well as a strong understanding of the employees and markets served by Investors Bank. This experience provides a unique perspective to the Board of Directors. The Nominating and Corporate Governance Committee considers Ms. Byrnes’ skills and experience to be assets to the Board of Directors. |
William V. Cosgrove non-Section 16 officer of Investors Bank since Investors Bancorp’s acquisition of Summit Federal Bankshares, Inc. and Summit Federal Savings Bank in June 2008 through his retirement from Investors Bank on October 1, 2011. Mr. Cosgrove was President and Chief Executive Officer of Summit Federal Savings Bank from 2003 until the acquisition of Summit Federal Savings Bank by Investors Bank in 2008. Mr. Cosgrove has over 50 years of experience in banking and has served as president of the N.J. Council of Federal Savings Institutions, and the Union County Savings League. In addition, he served on the Board of Governors of the New Jersey Savings League. Mr. Cosgrove is a member of the NACD, where he continues his education.Mr. Cosgrove’s extensive experience in the banking industry and local markets bring valuable expertise to the Board of Directors. The Nominating and Corporate Governance Committee considers Mr. Cosgrove’s financial and leadership skills and his experience and knowledge of the financial services industry in general to be assets to the Board of Directors. | ||
Kevin Cummings 26-year career with the independent accounting firm of KPMG LLP, where he had been partner for 14 years. Immediately prior to joining Investors Bank, he was an audit partner in KPMG’s Financial Services practice in their New York City office and lead partner on a major commercial banking client. Mr. Cummings also worked in the New Jersey community bank practice for over 20 years. Mr. Cummings has a Bachelor’s degree in Economics from Middlebury College and a Master’s degree in Business Administration from Rutgers University. He is the former Chairman of the Board of the New Jersey Bankers Association and sits on the Board of Trustees of the Scholarship Fund for Inner-City Children and the Board of Trustees at St. Benedict’s Preparatory School. In addition, Mr. Cummings is a member of the Board of the Federal Home Loan Bank of New York and the Community Foundation of New Jersey.Mr. Cummings is a certified public accountant and his background in public accounting enhances the board of directors’ oversight of financial reporting and disclosure issues. The Nominating and Corporate Governance Committee considers Mr. Cummings’ leadership skills and knowledge of accounting, auditing and corporate governance in the financial services industry to be assets to the Board of Directors. | ||
John E. Harmon, Sr. The Nominating and Corporate Governance Committee considers Mr. Harmon’s skills and experience in community and business development, inclusion and finance to be assets to the Board of Directors. |
Michele N. Siekerka Mid-Atlantic, first as vice president of human resources and then as senior counsel. Active in numerous civic/professional organizations, Ms. Siekerka is on the Board of Choose New Jersey, New Jersey Innovation Institute, Junior Achievement of New Jersey, the National Association of Corporate Directors NJ Chapter and the Council of State Manufacturing Associations where she also serves as an Executive Committee member. Ms. Siekerka is a former member of the Robbinsville Township Board of Education where she served as President from 2002 to 2005. Professional certifications include NACD Directorship Certification, NACD Board Fellowship and Ford Foundation Fellowship for Regional Sustainable Development.The Nominating and Corporate Governance Committee considers Ms. Siekerka’s legal and government affairs expertise and market knowledge to be assets to the Board of Directors. | ||
Paul N. Stathoulopoulos to-date. Starting in 1969, Mr. Stathoulopoulos was employed by the Atlantic Bank of New York, where his last position was Senior Vice President & Officer-in-Charge Mr. Stathoulopoulos has extensive knowledge of the banking industry and local markets served by Investors Bank. The Nominating and Corporate Governance Committee considers Mr. Stathoulopoulos’s experience and leadership to be assets to the Board of Directors. | ||
Kim Wales The Nominating and Corporate Governance Committee considers Ms. Wales’s skills and experience in technology, fintech and information security to be assets to the Board of Directors. |
Richard S. Spengler 21-year career with First Savings Bank, Woodbridge, New Jersey where he served as Executive Vice President and Chief Lending Officer from 1999 to 2004. Mr. Spengler holds a Bachelor’s degree in Business Administration from Rutgers University. | ||
Paul Kalamaras | ||
Sean Burke |
✓ |
The Board and management regularly focus on strategy and planning. |
✓ |
Of the Board’s current 12 Directors, 9 are independent, including the Lead Independent Director. |
✓ |
Our Board has adopted a majority voting policy, described below, which requires directors who do not receive majority stockholder support to tender their resignation. |
✓ |
We have regular and constructive engagement with our stockholders and evaluate and respond to their views and requests. |
✓ |
The Board held 9 regularly scheduled meetings in 2021. The Board also held 6 special meetings relating to the Company’s proposed merger with Citizens. The Board’s Committees each held 4 to 6 meetings in 2021. The Board met in executive session 9 times, 5 of which were presided over by the Board’s Lead Independent Director. |
✓ |
Our Director attendance for Board and Committee meetings averaged approximately 99% in 2021, and each Director attended at least 75% of Board and Committee meetings on which the Director served. |
✓ |
The Board conducts annual self-evaluations. |
✓ |
New Directors are provided with an orientation package and attend Board orientation and policy training sessions. |
✓ |
The Board has a robust Director Education Program to keep abreast of significant risks and compliance issues; laws, regulations and requirements applicable to the Company; corporate governance best practices; products and services offered by the Company; changes in the financial services industry; and enhancements in technology and platforms relating to the financial services industry and the delivery and availability of banking products and services. |
✓ |
Robust stock ownership guidelines for directors and Named Executive Officers are in place. |
✓ |
We have specific policies and procedures to align executive compensation with long-term stockholder interests; these policies and procedures are routinely reviewed and appropriately revised by the Compensation and Benefits Committee in conjunction with an independent compensation consultant. |
✓ |
We have a clawback policy that applies to the performance-based incentive compensation paid to our Named Executive Officers. |
✓ |
The Board reviews management talent and succession planning at least annually. |
✓ |
The Company makes ongoing investments in systems and technology, as well as training and education for all employees and Directors to combat cybersecurity threats. |
✓ |
The Board understands the importance of maintaining regular, open, and transparent communications with our regulators. |
✓ |
Our Board has oversight of risk management with a focus on the most significant enterprise risks facing our Company, including compliance, credit, legal, liquidity, market, operational, cybersecurity, reputational, and strategic risks. |
✓ |
We have guidelines governing the use of pre-established trading plans for transactions in our securities. |
✓ |
The Board actively utilizes internal and external experts in the matters of audit, governance, compensation, stockholder interests and risk management. |
✘ |
We prohibit all hedging of Investors Bancorp common stock by directors and executive officers. |
✘ |
We prohibit pledging of Investors Bancorp common stock as collateral by directors and executive officers. |
✘ |
We prohibit short sales of Investors Bancorp common stock by directors and executive officers. |
✘ |
No immediate family relationships exist between any of our directors or executive officers. |
Director |
Position(s) Held With Investors Bancorp |
Nominating and Corporate Governance Committee |
Audit Committee |
Compensation and Benefits Committee |
Risk Oversight Committee | |||||
Robert C. Albanese |
Director |
Chair(1) |
Member |
Member | ||||||
Dennis M. Bone |
Lead Independent Director |
Member |
Member |
Member |
Member | |||||
Doreen R. Byrnes |
Director |
Chair |
Member |
Member | ||||||
Domenick A. Cama |
Director, President and Chief Operating Officer |
|||||||||
William V. Cosgrove |
Director |
Member |
Member |
Member | ||||||
Kevin Cummings |
Chairman and Chief Executive Officer |
|||||||||
James J. Garibaldi |
Director |
Member | ||||||||
John E. Harmon, Sr. |
Director |
Member |
Member |
Member | ||||||
Michele N. Siekerka |
Director |
Member |
Chair |
Member | ||||||
Paul N. Stathoulopoulos |
Director |
Member(1) |
Member |
Member | ||||||
Kim Wales |
Director |
Member |
Member |
Member | ||||||
James H. Ward III |
Director |
Member |
Member |
Chair | ||||||
Number of Meetings |
4 |
6 |
6 |
4 |
(1) |
The Board considers Messrs. Albanese and Stathoulopoulos each an “audit committee financial expert”. |
Director |
Diverse |
Audit/ Accounting/ Finance/ Capital Allocation |
Banking and Financial Services |
Executive Level Experience |
Business Operations and Technology |
Risk Management |
Human Capital Management |
Environmental/ Social/ Governance | ||||||||
Robert C. Albanese | • | • | • | • | • | |||||||||||
Dennis M. Bone | • | • | • | • | • | |||||||||||
Doreen R. Byrnes | • | • | • | • | • | • | ||||||||||
Domenick A. Cama | • | • | • | • | • | • | ||||||||||
William V. Cosgrove | • | • | • | • | • | • | • | |||||||||
Kevin Cummings | • | • | • | • | ||||||||||||
James J. Garibaldi | • | • | • | |||||||||||||
John E. Harmon, Sr. | • | • | • | • | • | • | ||||||||||
Michele N. Siekerka | • | • | • | • | • | • | • | |||||||||
Paul N. Stathoulopoulos | • | • | • | • | • | |||||||||||
Kim Wales | • | • | • | • | • | • | ||||||||||
James H. Ward III | • | • | • | • | • |
• | Preside at all meetings of the independent outside directors and independent directors; |
• | Coordinate as necessary Company-related activities of the independent outside directors; |
• | Facilitate communications among the Chairman of the Board, Company management and the independent outside directors; |
• | Consult with the Chairman of the Board with respect to meeting agendas and schedules, as well as Board materials, prior to Board meetings; |
• | Consult with the Chairman of the Board to assure that appropriate topics are being discussed with sufficient time allocated for each; |
• | Preside at Board meetings when the Chairman is not present; |
• | Approve all meeting agendas for the Board; |
• | Solicit and receive topic suggestions from other directors to be discussed at upcoming executive sessions and facilitate discussion on key issues outside of meetings; |
• | If requested by our larger stockholders, ensure that he or she is available for consultation and direct communication with them; |
• | Follow up on meeting outcomes and management deliverables; |
• | Communicate, as appropriate, with our regulators; |
• | Meet regularly with the Chairman/CEO on issues and opportunities facing the Company, including business strategy, regulatory matters and succession planning; and |
• | Act as an advisor to the Chairman/CEO. |
• | Mission of the Board; |
• | Board size and composition; |
• | Director responsibilities and qualifications; |
• | Lead Independent Director responsibilities; |
• | Independence standards for Directors; |
• | Board nominating procedures and election criteria; |
• | Board committees; |
• | Director access to officers and employees; |
• | Stock ownership policies; |
• | Director compensation; |
• | Director continuing education; |
• | Annual Director performance evaluation; |
• | Annual CEO evaluation and succession; and |
• | Our Code of Business Conduct and Ethics. |
• | Lead the search for individuals qualified to become members of the Board of Directors and develop criteria (such as independence, experience relevant to the needs of the Company, leadership qualities, diversity, stock ownership) for board membership; |
• | Make recommendations to the Board concerning Board nominees and stockholder proposals; |
• | Develop, recommend and oversee the annual self-evaluation process of the Board and its committees; |
• | Develop and annually review corporate governance guidelines applicable to the Company; |
• | Review and monitor the Board’s compliance with Nasdaq corporate governance listing rules for independence; and |
• | Review, in consultation with the Compensation and Benefits Committee, Directors’ compensation and benefits. |
• | a statement that the writer is a stockholder and is proposing a candidate for consideration by the Nominating and Corporate Governance Committee; |
• | the qualifications of the candidate and why this candidate is being proposed; |
• | the name, address and contact information for the nominated candidate, and the number of shares of Investors Bancorp common stock that are owned by the candidate (if the candidate is not a holder of record, appropriate evidence of the stockholder’s ownership should be provided); |
• | the name and address of the nominating stockholder as he/she appears on Investors Bancorp’s books, and number of shares of Investors Bancorp common stock that are owned beneficially by such stockholder (if the stockholder is not a holder of record, appropriate evidence of the stockholder’s ownership will be required); |
• | a statement of the candidate’s business and educational experience; |
• | such other information regarding the candidate as would be required to be included in a proxy statement pursuant to SEC Regulation 14A; |
• | a statement detailing any relationship between the candidate and Investors Bancorp and between the candidate and any customer, supplier or competitor of Investors Bancorp; |
• | detailed information about any relationship or understanding between the proposing stockholder and the candidate; and |
• | a statement that the candidate is willing to be considered and willing to serve as a director if nominated and elected. |
• | Forward the communication to the director(s) to whom it is addressed; |
• | Handle the inquiry directly, for example where it is a request for information about Investors Bancorp or it is a stock-related matter; or |
• | Not forward the communication if it is primarily commercial in nature, relates to an improper or irrelevant topic, or is unduly hostile, threatening, illegal or otherwise inappropriate |
• | The integrity of Investors Bancorp’s financial statements; |
• | Investors Bancorp’s compliance with legal and regulatory requirements; |
• | The independent auditor’s qualifications and independence; |
• | The performance of Investors Bancorp’s internal audit function and independent auditor; and |
• | Investors Bancorp’s system of disclosure controls and system of internal controls regarding finance, accounting, and legal compliance. |
• | Retain, oversee and evaluate a firm of independent registered public accountants to audit the annual financial statements; |
• | Review the integrity of Investors Bancorp’s internal control over financial reporting, both internal and external, in consultation with the independent registered public accounting firm and the internal auditor; |
• | Review the financial statements and the audit report with management and the independent registered public accounting firm; |
• | Review earnings and financial releases and quarterly and annual reports filed with the SEC; and |
• | Approve all engagements for audit and non-audit services by the independent registered public accounting firm. |
• | reviewed and discussed with management, and the independent registered public accounting firm, the audited consolidated financial statements and the internal control procedures of Investors Bancorp for the year ended December 31, 2021; |
• | discussed with the independent registered public accounting firm the matters required to be discussed |
• | by the applicable requirements of the PCAOB and the SEC; and |
• | received the written disclosures and the letter from the independent registered public accounting firm required by applicable requirements of the PCAOB regarding the independent registered public accounting firm’s communications with the Audit Committee concerning independence, and has discussed with the independent registered public accounting firm its independence from Investors Bancorp. |
• | Review and recommend to the independent directors of the Board for approval the Chief Executive Officer’s annual compensation, including salary, cash incentive, and equity compensation; |
• | Review and recommend to the Board the evaluation process and compensation for Investors Bancorp’s executive officers and coordinate compensation determinations and benefit plans for all employees of Investors Bancorp; |
• | Review Investors Bancorp’s incentive compensation and equity-based plans and make changes in such plans as needed; |
• | Review, as appropriate and in consultation with the Nominating and Corporate Governance Committee, director compensation and benefits; and |
• | Review the independence of the Compensation and Benefits Committee members, legal counsel and compensation consultants. |
• | Review and discuss with management and the independent registered public accounting firm, the audited net assets of the 401(k) Plan and the financial statements of the ESOP. |
Compensation Element |
Director Compensation ($) |
|||
Annual Fee for Investors Bancorp Non-Employee Director |
24,000 | |||
Annual Fee for Investors Bank Non-Employee Director |
73,200 | |||
Annual Fee for Lead Independent Director |
25,000 | |||
Annual Fee for Committee Chair |
10,000 | |||
Annual Fee for Audit Committee Member |
15,000 | |||
Annual Fee for Compensation and Benefits Committee Member |
15,000 | |||
Annual Fee for Nominating and Corporate Governance Committee Member |
7,500 | |||
Annual Fee for Risk Oversight Committee Member |
10,000 |
Name |
Investors Bancorp Fees Earned or Paid in Cash ($) |
Investors Bank Fees Earned or Paid in Cash ($) |
Stock Awards ($) (1) |
Option Awards ($) (2) |
Change in Pension Value and Nonqualified Deferred Compensation Earnings ($) |
All Other Compensation ($) (3) |
Total ($) |
|||||||||||||||||||||
Robert C. Albanese |
74,000 | 73,200 | — | — | — | 654 | 147,854 | |||||||||||||||||||||
Dennis M. Bone |
96,500 | 73,200 | — | — | — | 495 | 170,195 | |||||||||||||||||||||
Doreen R. Byrnes |
66,500 | 73,200 | — | — | — | 17,905 | 157,605 | |||||||||||||||||||||
William V. Cosgrove |
56,500 | 73,200 | — | — | — | 30,129 | 159,829 | |||||||||||||||||||||
James J. Garibaldi |
34,000 | 73,200 | — | — | — | — | 107,200 | |||||||||||||||||||||
John E. Harmon, Sr. |
44,292 | 67,100 | — | — | — | — | 111,392 | |||||||||||||||||||||
Michele N. Siekerka |
66,500 | 73,200 | — | — | — | 172 | 139,872 | |||||||||||||||||||||
Paul N. Stathoulopoulos |
64,000 | 73,200 | — | — | — | 5,412 | 142,612 | |||||||||||||||||||||
Kim Wales |
48,667 | 67,100 | — | — | — | — | 115,767 | |||||||||||||||||||||
James H. Ward III |
74,000 | 73,200 | — | — | — | — | 147,200 |
(1) | Messrs. Albanese, Bone, Cosgrove, Garibaldi, Stathoulopoulos and Ward and Mses. Byrnes and Siekerka each had no unvested stock awards at December 31, 2021. |
(2) | Messrs. Albanese, Bone, Cosgrove, Garibaldi, Stathoulopoulos and Ward and Mses. Byrnes and Siekerka each had no unexercised stock option awards at December 31, 2021. |
(3) | This amount includes perquisites and other personal benefits, or property, if the aggregate amount for each director is at least $10,000. Specifically, this amount represents the premiums paid for long term care coverage for Ms. Byrnes and her spouse. In addition, the amount includes automobile allowance and club dues for Mr. Cosgrove. For Messrs. Albanese, Bone and Stathoulopoulos and Ms. Siekerka, this amount includes imputed income with respect to their split dollar life insurance agreements. |
Number of Securities to be Issued Upon Exercise of Outstanding Options and Rights (1) |
Weighted Average Exercise Price (2) |
Number of Securities Remaining Available for Issuance Under Plan |
||||||||||
Equity compensation plans approved by stockholders |
5,570,858 | $ | 12.46 | 17,529,907 | ||||||||
Equity compensation plans not approved by stockholders |
— | — | — | |||||||||
Total |
5,570,858 | — | 17,529,907 |
(1) | Includes outstanding stock options to purchase 120,564 shares of common stock granted under the 2006 Equity Incentive Plan. |
(2) | With respect to the stock options, the weighted average exercise price reflects an exercise price of $8.15 for 73,491 stock options granted in 2013; an exercise price of $10.28 for 47,073 stock options granted in 2014; an exercise price of $12.54 for 4,241,158 stock options granted in 2015; an exercise price of $11.83 for 110,560 stock options granted in 2016; an exercise price of $13.29 for 63,360 stock options granted in 2017; an exercise price of $12.99 for 40,000 stock options granted in 2018 and an exercise price of $12.53 for 995,216 stock options granted in 2019 under the Company’s stock-based compensation plans. |
(3) | Represents the number of available shares that may be granted as stock options and other stock awards under the Company’s stock-based compensation plans. |
Name |
Title | |
Kevin Cummings | Chairman and Chief Executive Officer | |
Domenick A. Cama | President and Chief Operating Officer | |
Richard S. Spengler | Senior Executive Vice President and Chief Lending Officer | |
Sean Burke | Executive Vice President and Chief Financial Officer | |
Paul Kalamaras | Senior Executive Vice President and Chief Risk Officer |
• | There were no base salary increases in 2021 for our CEO or COO, but the base salary for Messrs. Spengler and Burke were increased to $480,000 and $475,000, respectively, in 2021. |
• | There were no restricted stock awards or stock options granted in 2021 to our CEO, COO or other NEOs. |
• | The Compensation and Benefits Committee advised our stockholders it might exercise discretion for 2020 incentive compensation in light of the COVID-19 pandemic. The Committee decided not to use discretion for the CEO and COO and therefore their incentive goals, targets and measurements remained unchanged. |
• | The CEO’s and COO’s incentive goals were measured exclusively by specific corporate goals tied to the financial results of the Company and did not include any individual goals. |
• | For all employees, including our NEOs, the Company had to achieve net income at a level equal to or greater than 75% of the net income target amount for 2021 for any incentive to be paid, including incentives related to individual goals. |
• | The 2021 target and maximum net income goal amounts were set to exceed 2020 achievement. |
• | The Company’s net income exceeded 75% of the net income target amount for 2021 which enabled the CEO’s and COO’s incentive compensation to be measured on a balanced scorecard for the following Company financial components: |
• | Earnings per share |
• | Return on average assets |
• | Loan quality |
• | Based on the achievement of the corporate financial targets for the CEO and COO and corporate financial targets and individual goals for the other NEOs, the annual cash incentive awards were paid, between 105% and 175% of base salary, to our NEOs. |
What We Do |
What We Don’t Do | |
✓ We design our incentive compensation arrangements to appropriately balance risk and financial results in a manner that does not pose undue risk to the Company. ✓ We utilize an independent compensation consultant to annually evaluate NEO cash and stock compensation based on the pay levels of comparable executives in fifteen-to-twenty ✓ We pay incentive compensation based on measurable and verifiable corporate performance objectives. ✓ We consider multi-year financial performance when awarding long-term stock compensation. ✓ We conservatively vest stock compensation (generally five years). ✓ We require each of our NEOs to own Company common stock valued at a minimum of three-to-five ✓ We maintain a clawback policy for bonus and other incentive compensation paid to executive officers, which mitigates risk-taking behavior. ✓ We will place greater weight on performance when granting future equity awards. |
✗ We don’t modify annual incentive compensation performance objectives during the year in which those objectives apply. ✗ We don’t require the base salaries and total cash compensation of our NEOs to attain any particular percentile position versus the compensation of executives in our peer comparator companies. ✗ We don’t allow directors and executive officers to engage in or effect transactions designed to hedge or offset economic risk of owning shares of our stock. ✗ We don’t allow directors and executive officers to hold company stock in a margin account or pledge securities as collateral. ✗ We don’t enter into new change of control agreements with single triggers. ✗ We have only limited perquisites. ✗ We don’t enter into new employment contracts with tax gross up provisions. |
BankUnited—FL |
Signature Bank—NY | |
Commerce Bancshares, Inc.—MO |
Sterling Bancorp—NY | |
First Horizon National Corporation —TN |
UMB Financial Corporation—MO | |
Flagstar Bancorp—MI |
Umpqua Holdings Corporation—OR | |
F.N.B Corporation—PA |
Valley National Bancorp—NJ | |
Fulton Financial Corporation— PA |
Webster Financial Corporation—CT | |
New York Community Bancorp, Inc.—NY |
Western Alliance Bancorporation—AZ | |
Old National Bancorp—IN |
Wintrust Financial Corporation—IL | |
Prosperity Bancshares, Inc.—TX |
Executive Officer |
2021 Salary ($) |
2020 Salary ($) |
||||||
Kevin Cummings |
1,075,000 | 1,075,000 | ||||||
Domenick A. Cama |
725,000 | 725,000 | ||||||
Richard S. Spengler |
480,000 | 465,000 | ||||||
Sean Burke |
475,000 | 450,000 | ||||||
Paul Kalamaras |
450,000 | 450,000 |
ISBC 2020 |
ISBC 2021 |
|||||||
Net Income (in millions) |
$ | 221.6 | $ | 313.3 | ||||
EPS |
$ | 0.94 | $ | 1.33 |
ISBC 2021 |
Peers 2021 |
|||||||
ROAA – Return on Average Assets |
1.17 | % | 1.16 | % | ||||
Credit Quality – Non Performing Assets/ Assets |
0.42 | % | 0.43 | % | ||||
Capital Levels – Common Equity Tier 1 Ratio |
12.82 | % | 11.58 | % | ||||
Total Shareholder Return – Year Ended December 31, 2021 |
15.22 | % | 4.96 | % |
Executive Officer |
Threshold (1) |
Target (1) |
Maximum (1) |
|||||||||
Kevin Cummings |
87.5 | % | 131.3 | % | 175.0 | % | ||||||
Domenick A. Cama |
70.0 | % | 105.0 | % | 140.0 | % | ||||||
Richard S. Spengler |
52.5 | % | 78.8 | % | 105.0 | % | ||||||
Sean Burke |
52.5 | % | 78.8 | % | 105.0 | % | ||||||
Paul Kalamaras |
52.5 | % | 78.8 | % | 105.0 | % |
(1) | Assumed 50%, 75% and 100% achievement of all individual goals at Threshold, Target and Maximum, respectively. |
Executive Officer |
Corporate Financial Targets |
Individual Goals |
||||||
Kevin Cummings |
100 | % | 0 | % | ||||
Domenick A. Cama |
100 | % | 0 | % | ||||
Richard S. Spengler |
40 | % | 60 | % | ||||
Sean Burke |
60 | % | 40 | % | ||||
Paul Kalamaras |
30 | % | 70 | % |
Metric |
Threshold 50% Payout |
Target 75% Payout |
Maximum 100% Payout |
|||||||||
Net income (in millions) |
$ | 225 | $ | 245 | $ | 265 | ||||||
Earnings per share |
$ | 0.97 | $ | 1.05 | $ | 1.14 | ||||||
Return on average assets |
0.82 | % | 0.89 | % | 0.97 | % | ||||||
Loan quality |
10.00 | % | 7.00 | % | 5.00 | % |
• | Mr. Spengler’s individual goals included loan delinquencies to remain within a range of variances to our peer group. In addition, specific metrics were established with a range of attainment between threshold and maximum for loan growth and deposit growth. |
• | Mr. Kalamaras’ individual goals included implementation of effective information security controls associated with the migration of on premises data centers to a cloud based platform, enhancement of the bank’s Community Reinvestment Act program which included lending, service and investment elements, assessment of the effectiveness of the Bank’s business continuity program, expanding oversight of disaster recovery readiness and ransomware recovery, and implementation of enhanced fraud mitigation technologies. |
• | Mr. Burke’s individual goals were related to enhancing profitability and regulatory reporting, refining the allowance for credit loss presentation, and the evaluation of tax strategies. |
($ in millions) |
Net Income |
EPS |
||||||
Reported |
$ | 313.3 | $ | 1.33 | ||||
Cost of early extinguishment of wholesale funding |
10.2 | 0.04 | ||||||
Branch rationalization costs |
6.6 | 0.03 | ||||||
Acquisition-related expenses |
11.5 | 0.04 | ||||||
Shareholder matter |
0.3 | 0.00 | ||||||
Tax impact |
(7.7 | ) | (0.03 | ) | ||||
Adjusted |
$ | 334.2 | $ | 1.41 |
EPS (adjusted) |
ROAA (adjusted) |
Loan Quality |
||||||||||
Achievement |
100 | % | 100 | % | 100 | % | ||||||
Executive Officer |
EPS Weighting |
ROAA Weighting |
Loan Quality Weighting |
|||||||||
Kevin Cummings |
50 | % | 30 | % | 20 | % | ||||||
Domenick A. Cama |
50 | % | 30 | % | 20 | % | ||||||
Richard S. Spengler |
50 | % | 50 | % | n/a | |||||||
Sean Burke |
50 | % | 50 | % | n/a | |||||||
Paul Kalamaras |
50 | % | 50 | % | n/a |
Bonus Guidelines |
Achievement |
|||||||||||||||||||||||||||||||
Executive Officer |
Eligible Earnings ($) |
Maximum Bonus (%) |
Corporate Goals |
Individual Goals |
Corporate Goals |
Individual Goals |
Cash Incentive ($) |
Percent of Salary |
||||||||||||||||||||||||
Kevin Cummings |
1,075,000 | 175 | % | 100 | % | 0 | % | 100 | % | NA | 1,881,250 | 175 | % | |||||||||||||||||||
Domenick A. Cama |
725,000 | 140 | % | 100 | % | 0 | % | 100 | % | NA | 1,015,000 | 140 | % | |||||||||||||||||||
Richard S. Spengler |
480,000 | 105 | % | 40 | % | 60 | % | 100 | % | 100 | % | 504,000 | 105 | % | ||||||||||||||||||
Sean Burke |
475,000 | 105 | % | 60 | % | 40 | % | 100 | % | 100 | % | 498,750 | 105 | % | ||||||||||||||||||
Paul Kalamaras |
450,000 | 105 | % | 30 | % | 70 | % | 100 | % | 100 | % | 472,500 | 105 | % |
Name |
Award Type |
2015 Original Awards ($) (1) |
2019 Replacement Awards ($) (2) |
Change in Fair Value ($) |
||||||||||||
Kevin Cummings |
Stock Options | 4,159,999 | 467,357 | (3,692,642 | ) | |||||||||||
Restricted Stock | 12,540,000 | 10,230,500 | (2,309,500 | ) | ||||||||||||
|
|
|
|
|
|
|||||||||||
16,699,999 | 10,697,857 | (6,002,142 | ) | |||||||||||||
Domenick A. Cama |
Stock Options | 3,327,998 | 373,885 | (2,954,113 | ) | |||||||||||
Restricted Stock | 10,032,000 | 8,184,400 | (1,847,600 | ) | ||||||||||||
|
|
|
|
|
|
|||||||||||
13,359,998 | 8,558,285 | (4,801,713 | ) |
(1) | Represents the grant date fair value of the awards determined in accordance with FASB ASC Topic 718. Assumptions used in the calculation of these amounts are included in Note 11 to the audited financial statements included in the Annual Report on Form 10-K for the calendar year ended December 31, 2015. The fair value of the stock option awards was $3.12 as computed in accordance with FASB ASC Topic 718. The stock price on June 23, 2015 was $12.54. In 2018, Messrs. Cummings and Cama forfeited performance-based restricted shares with a grant date fair value of $940,500 and $752,400, respectively, as the performance-based restricted shared were deemed earned at 70% of target. |
(2) | Represents the grant date fair value of the awards determined in accordance with FASB ASC Topic 718. Assumptions used in the calculation of these amounts are included in Note 12 to the audited financial statements included in the Annual Report on Form 10-K for the calendar year ended December 31, 2019. The fair value of the stock option awards was $0.89 as computed in accordance with FASB ASC Topic 718. The stock price on July 22, 2019 was $11.06. |
Name and Principal Position |
Year |
Salary ($) |
Bonus ($) |
Stock Awards ($) (1) (2) |
Option Awards ($) (1) (2) |
Non-Equity Incentive Plan Compensation ($) (3) |
Increase in Pension Value and Nonqualified Deferred Compensation Earnings ($) (4) |
All Other Compensation ($) (5) |
Total ($) |
Total Without Change in Pension Value ($) |
||||||||||||||||||||||||||||||
Kevin Cummings, Chairman and Chief Executive Officer |
|
2021 2020 2019 |
|
|
1,075,000 1,075,000 1,075,000 |
|
|
— — — |
|
|
— — — |
|
|
— — — |
|
|
1,881,250 1,716,641 1,373,548 |
|
|
336,000 3,109,000 2,755,000 |
|
|
217,986 182,718 207,804 |
|
|
3,510,236 6,083,359 5,411,352 |
|
|
3,174,236 2,974,359 2,656,352 |
| ||||||||||
Domenick A. Cama, President and Chief Operating Officer |
|
2021 2020 2019 |
|
|
725,000 725,000 725,000 |
|
|
— — — |
|
|
— — — |
|
|
— — — |
|
|
1,015,000 926,188 741,077 |
|
|
312,000 1,415,000 1,692,000 |
|
|
185,112 154,916 161,707 |
|
|
2,237,112 3,221,104 3,319,784 |
|
|
1,925,112 1,806,104 1,627,784 |
| ||||||||||
Richard S. Spengler, Senior Executive Vice President and Chief Lending Officer |
|
2021 2020 2019 |
|
|
480,000 465,000 465,000 |
|
|
— — — |
|
|
— — — |
|
|
— — — |
|
|
504,000 445,528 317,118 |
|
|
— 756,000 852,000 |
|
|
100,680 90,360 85,282 |
|
|
1,084,680 1,756,888 1,719,400 |
|
|
1,084,680 1,000,888 867,400 |
| ||||||||||
Sean Burke, Executive Vice President and Chief Financial Officer |
|
2021 2020 2019 |
|
|
475,000 450,000 450,000 |
|
|
— — — |
|
|
— — — |
|
|
— — — |
|
|
498,750 441,485 412,493 |
|
|
— 6,000 7,000 |
|
|
92,917 75,704 87,511 |
|
|
1,066,667 973,189 957,004 |
|
|
1,066,667 967,189 950,004 |
| ||||||||||
Paul Kalamaras, Senior Executive Vice President and Chief Risk Officer |
|
2021 2020 2019 |
|
|
450,000 450,000 450,000 |
|
|
— — — |
|
|
— — — |
|
|
— — — |
|
|
472,500 456,993 412,493 |
|
|
— 548,000 636,000 |
|
|
87,411 94,307 92,059 |
|
|
1,009,911 1,549,300 1,590,552 |
|
|
1,009,911 1,001,300 954,552 |
|
(1) | As part of the shareholder litigation settlement in 2019, Mr. Cummings and Mr. Cama surrendered stock awards with a grant date fair value of $11.6 million and $9.3 million, respectively, and stock options with a grant date fair value of $4.2 million and $3.3 million, respectively. Mr. Cummings and Mr. Cama received Replacement Awards of stock awards with a grant date fair value of $10.2 million and $8.2 million, respectively, and stock options with a grant date fair value of $467,357 and $373,885, respectively. These transactions were accounted for as a modification of the original grant and there was no incremental expense to the Company or compensation to the employees as the grant date fair value of the surrendered awards was $5.1 million and $4.0 million higher than the grant date fair value of the Replacement Awards for Mr. Cummings and Mr. Cama, respectively. |
(2) | The amounts in this column reflect the aggregate grant date fair value computed in accordance with FASB ASC 718, of restricted stock and stock option awards granted pursuant to the 2015 Equity Incentive Plan. The annual financial statement expense that we are required to recognize for these grants will be expensed ratably over the vesting period, but SEC rules require that we report the full grant date fair value of restricted stock and stock option awards in the year in which the grants are made even though the value cannot be received by the officers in that year. Other than the Replacement awards noted above, there were no restricted stock or stock option awards grant to the NEOs for the three-year period 2019-2021. |
(3) | The amounts were earned pursuant to the Executive Officer Annual Incentive Plan. |
(4) | Effective December 31, 2016, the Defined Benefit Plan and SERP II was frozen. The amounts in this column reflect the aggregate change in the actuarial present value of the NEO’s accumulated benefit under all defined benefit and actuarial pension plans (including non-qualified supplemental plans) from the measurement date in the immediately preceding calendar year to the measurement date in such calendar year, determined using the interest rate and mortality rate assumptions consistent with those used in Investors Bancorp’s financial statements. For 2020 and 2019, the change in the pension value was primarily a result of the decrease in the discount rate assumption due to market conditions. In particular, 61% and 78% of Mr. Cummings’ change in pension value in 2020 and 2019, respectively, was due solely to changes in the discount rate. Earnings under the SERP I attributable to the Supplemental ESOP Benefit are not included in this column because the earnings were not “above-market,” as defined by the SEC. |
(5) | The amounts in this column represent all other compensation not reported in prior columns in this table, including perquisites, the aggregate value of which exceeds $10,000, and employer contributions to defined contribution plans. See the “All Other Compensation” and “Perquisites” tables below for a breakdown of these amounts for the year ended December 31, 2021. |
Name |
Calendar or Fiscal Year |
Perquisites and Other Personal Benefits ($) (1) |
Company Contribution for Medical and Insurance Benefits ($) |
Company Contributions to ESOP and 401 (k) Plan and SERP I ($) |
Total ($) |
|||||||||||||||
Kevin Cummings |
2021 | 23,616 | 27,663 | 166,707 | 217,986 | |||||||||||||||
Domenick A. Cama |
2021 | 54,105 | 29,528 | 101,479 | 185,112 | |||||||||||||||
Richard S. Spengler |
2021 | 17,236 | 23,470 | 59,974 | 100,680 | |||||||||||||||
Sean Burke |
2021 | 9,788 | 23,672 | 59,457 | 92,917 | |||||||||||||||
Paul Kalamaras |
2021 | 24,271 | 4,226 | 58,914 | 87,411 |
(1) | A detailed description of the perquisites included in this column is set forth in the table below. |
Name |
Calendar or Fiscal Year |
Automobile Allowance ($) |
Long Term Care ($) |
Club Dues ($) |
Executive Health Exam/Health Club Dues ($) |
Total Perquisites and Other Personal Benefits ($) |
||||||||||||||||||
Kevin Cummings |
2021 | 9,089 | 12,329 | 2,198 | — | 23,616 | ||||||||||||||||||
Domenick A. Cama |
2021 | 20,588 | 16,008 | 17,509 | — | 54,105 | ||||||||||||||||||
Richard S. Spengler |
2021 | 7,702 | 2,633 | 6,902 | — | 17,236 | ||||||||||||||||||
Sean Burke |
2021 | 9,788 | — | — | — | 9,788 | ||||||||||||||||||
Paul Kalamaras |
2021 | 10,382 | 12,262 | 1,627 | — | 24,271 |
Estimated Payouts Under Non-Equity Incentive Plan Awards (1) |
All Other Stock Awards Number of Shares of Units (#) |
All Other Option Awards Number of Securities Underlying Options (#) |
Exercise or Base Price of Option Awards ($/Sh) |
Grant Date Fair Value of Stock and Option Awards ($) |
||||||||||||||||||||||||||||
Name |
Grant Date |
Threshold ($) |
Target ($) |
Maximum ($) |
||||||||||||||||||||||||||||
Kevin Cummings |
2/22/2021 | 940,625 | 1,410,938 | 1,881,250 | — | — | — | — | ||||||||||||||||||||||||
Domenick A. Cama |
2/22/2021 | 507,500 | 761,250 | 1,015,000 | — | — | — | — | ||||||||||||||||||||||||
Richard S. Spengler |
2/22/2021 | 252,000 | 378,000 | 504,000 | — | — | — | — | ||||||||||||||||||||||||
Sean Burke |
2/22/2021 | 249,375 | 374,063 | 498,750 | — | — | — | — | ||||||||||||||||||||||||
Paul Kalamaras |
2/22/2021 | 236,250 | 354,375 | 472,500 | — | — | — | — |
(1) | Amounts shown assume achievement of 50%, 75% and 100% of individual goals at Threshold, Target and Maximum, respectively. The range of estimated possible payouts reflects potential award opportunities under the Executive Officer Annual Incentive Plan. |
Name |
Grant Date (1) |
Number of Securities Underlying Unexercised Options (#) Exercisable |
Number of Securities Underlying Unexercised Options (#) (2) Unexercisable |
Option Exercise Price ($) |
Option Expiration Date (3) |
Number of Shares or Units of Stock That Have Not Vested (#) (2) |
Market Value of Shares or Units of Stock That Have Not Vested ($) (4) |
Equity Incentive Plan Awards: Number of Unearned Shares, Units, or Other Rights That Have Not Vested (#) |
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($) |
|||||||||||||||||||||||||||
Kevin Cummings |
7/22/19 | 393,840 | 131,280 | $ | 12.54 | 6/23/25 | 126,588 | 1,917,808 | — | — | ||||||||||||||||||||||||||
Domenick A. Cama |
7/22/19 | 315,072 | 105,024 | $ | 12.54 | 6/23/25 | 101,270 | 1,534,241 | — | — | ||||||||||||||||||||||||||
Richard S. Spengler |
6/23/15 | 611,429 | 101,904 | $ | 12.54 | 6/23/25 | 57,143 | 865,716 | — | — | ||||||||||||||||||||||||||
2/27/17 | — | — | — | — | 12,000 | 181,800 | — | — | ||||||||||||||||||||||||||||
Sean Burke |
6/23/15 | 436,197 | 89,523 | $ | 12.54 | 6/23/25 | 50,000 | 757,500 | — | — | ||||||||||||||||||||||||||
2/27/17 | — | — | — | — | 8,000 | 121,200 | — | — | ||||||||||||||||||||||||||||
Paul Kalamaras |
6/23/15 | 611,429 | 101,904 | $ | 12.54 | 6/23/25 | 57,143 | 865,716 | — | — | ||||||||||||||||||||||||||
3/27/17 | — | — | — | — | 12,000 | 181,800 | — | — |
(1) | The awards with a grant date of July 22,2019 represent the Replacement Awards. Refer to the “Settlement of Stockholder Litigation” section in this Amendment No. 1 to the Annual Report on Form 10-K |
(2) | Stock option and restricted stock awards generally vest over a seven-year period commencing on the first anniversary of the date granted. |
(3) | Stock options generally expire if unexercised 10 years after the grant date. |
(4) | Amounts shown are based on the fair market value of Investors Bancorp common stock on December 31, 2021 of $15.15 |
Option Awards |
Stock Awards |
|||||||||||||||
Name |
Number of Shares Acquired on Exercise (#) |
Value Realized on Exercise ($) |
Number of Shares Acquired on Vesting (#) |
Value Realized on Vesting ($) |
||||||||||||
Kevin Cummings |
— | — | 126,583 | 1,830,390 | ||||||||||||
Domenick A. Cama |
— | — | 101,270 | 1,464,364 | ||||||||||||
Richard S. Spengler |
— | — | 69,137 | 986,281 | ||||||||||||
Sean Burke |
100,946 | 370,098 | 58,000 | 829,720 | ||||||||||||
Paul Kalamaras |
— | — | 69,137 | 1,002,961 |
Name |
Plan Name |
Number of Years Credited Service ($) (1) |
Present Value of Accumulated Benefit ($) (2) |
Payment During Last Year ($) |
||||||||||
Kevin Cummings |
Defined Benefit Plan | 12.5 | 852,000 | — | ||||||||||
SERP I and SERP II | 12.5 | 23,255,000 | — | |||||||||||
Domenick A. Cama |
Defined Benefit Plan | 26.0 | 1,575,000 | — | ||||||||||
SERP I and SERP II | 26.0 | 11,871,000 | — | |||||||||||
Richard S. Spengler |
Defined Benefit Plan | 30.0 | 1,294,000 | — | ||||||||||
SERP I and SERP II | 30.0 | 3,679,000 | — | |||||||||||
Sean Burke |
Defined Benefit Plan | 0.9 | 33,000 | — | ||||||||||
SERP I and SERP II | — | — | — | |||||||||||
Paul Kalamaras |
Defined Benefit Plan | 7.3 | 361,000 | — | ||||||||||
SERP I and SERP II | 7.3 | 3,907,000 | — |
(1) | The number of years of credited service represents all years of service, including years following the change in benefit formula for the Defined Benefit Plan on January 1, 2006. For Messrs. Cama and Spengler, credited service years include qualified years served at other financial institutions that participated in the Defined Benefit Plan, formerly known as the Financial Institutions Retirement Fund. |
(2) | The figures shown are determined as of the plan’s measurement date of December 31, 2021 for purposes of Investors Bancorp’s audited financial statements. For discount rate and other assumptions used for this purpose, please refer to Note 13 to the audited financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2021. |
Name |
Plan Name |
Executive Contributions in Last Year ($) |
Registrant Contributions in Last Year ($) (1) |
Aggregate Earnings in Last Year ($) (2) |
Aggregate Withdrawals/ Distributions ($) |
Aggregate Balance at Last Year-End ($) (3) |
||||||||||||||||||
Kevin Cummings |
SERP I | — | 141,807 | 816,583 | — | 2,837,066 | ||||||||||||||||||
Domenick A. Cama |
SERP I | — | 76,579 | 414,614 | — | 1,445,075 | ||||||||||||||||||
Richard S. Spengler |
SERP I | — | 35,074 | 155,915 | — | 549,697 | ||||||||||||||||||
Sean Burke |
SERP I | — | 34,557 | 38,495 | — | 161,614 | ||||||||||||||||||
Paul Kalamaras |
SERP I | — | 34,014 | 122,632 | — | 438,781 |
(1) | The value of the non-qualified Supplemental ESOP contribution made pursuant to SERP I in calendar 2021 is based on the fair market value of Investors Bancorp common stock on December 31, 2021 of $15.15. These contributions are included in the Summary Compensation Table. |
(2) | The aggregate earnings for the Supplemental ESOP and Retirement Plan reflect the change in value of phantom shares issued prior to 2021, based on the fair market value of Investors Bancorp common stock on December 31, 2021 of $15.15. This amount is not included in the Summary Compensation Table because the rate of earnings was not “above-market,” as defined by the SEC |
(3) | The aggregate balances reported for the Supplemental ESOP Plan are based on the market value of Investors Bancorp common stock on December 31, 2021 of $15.15. For Messrs. Cummings, Cama, Spengler, Kalamaras and Burke, $1,624,778, $839,704, $331,734, $281,018 and $101,709, respectively, of their total aggregate balance was previously reported as compensation to them in our Summary Compensation Tables for previous years. |
Mr. Cummings |
Mr. Cama |
Mr. Spengler |
Mr. Kalamaras |
Mr. Burke |
||||||||||||||||
Retirement |
||||||||||||||||||||
Retiree Health/Life Insurance |
— | — | — | — | — | |||||||||||||||
Stock Option Vesting |
— | — | — | — | — | |||||||||||||||
Restricted Stock Vesting |
— | — | — | — | — | |||||||||||||||
Disability |
||||||||||||||||||||
Salary Continuation (1) |
2,959,182 | 1,909,182 | 1,174,182 | 1,084,182 | 1,159,182 | |||||||||||||||
Stock Option Vesting |
342,641 | 274,113 | 265,969 | 265,969 | 233,655 | |||||||||||||||
Restricted Stock Vesting |
1,917,808 | 1,534,241 | 1,047,516 | 1,047,516 | 878,700 | |||||||||||||||
Other benefits (2) |
24,920 | 27,382 | 10,435 | 24,842 | 22,977 | |||||||||||||||
Death |
||||||||||||||||||||
Salary Continuation (3) |
1,075,000 | 725,000 | 480,000 | 450,000 | 475,000 | |||||||||||||||
Stock Option Vesting |
342,641 | 274,113 | 265,969 | 265,969 | 233,655 | |||||||||||||||
Restricted Stock Vesting |
1,917,808 | 1,534,241 | 1,047,516 | 1,047,516 | 878,700 | |||||||||||||||
Other benefits (2) |
35,196 | 35,196 | 16,013 | 35,196 | 43,729 | |||||||||||||||
Discharge without Cause or Resignation with Good Reason (no Change in Control) |
||||||||||||||||||||
Stock Option Vesting |
— | — | — | — | — | |||||||||||||||
Restricted Stock Vesting |
— | — | — | — | — | |||||||||||||||
Salary and Cash Incentive (4)(5) |
12,929,465 | 7,505,440 | 3,030,300 | 3,192,747 |
2,921,251 | |||||||||||||||
Other benefits (2) |
139,049 | 139,049 | 115,938 | 139,049 | 169,344 | |||||||||||||||
Discharge without Cause or Resignation with Good Reason (Change in Control-related) |
||||||||||||||||||||
Stock Option Vesting |
342,641 | 274,113 | 265,969 | 265,969 | 233,655 | |||||||||||||||
Restricted Stock Vesting |
1,917,808 | 1,534,241 | 1,047,516 | 1,047,516 | 878,700 | |||||||||||||||
Salary and Cash Incentive (4)(5) |
12,929,465 | 7,505,440 | 3,030,300 | 3,192,747 | 2,921,251 | |||||||||||||||
Other benefits (2) |
139,049 | 139,049 | 115,938 | 139,049 | 169,344 | |||||||||||||||
Tax Indemnification Payment (6) |
— | — | — | — | — |
(1) | Upon disability, the NEO is entitled to base salary for the longer of the remaining term of his employment agreement or one year. Such benefit is reduced by the amount paid under our disability plan or policy, which is not reflected in this table. |
(2) | Other benefits include the estimated cost of providing, at the Company’s sole expense, substantially identical life insurance and nontaxable medical, dental and disability insurance coverage for each named executive officer for three (3) years pursuant to each named executive officer’s employment agreement. The amounts are estimated using the Company’s current cost of such benefits and an assumed 10% annual increase in the cost of benefits. The estimated amounts also assume that the benefits will be provided in-kind. If the Company cannot provide substantially identical benefits, the amount would be a cash lump sum payment reasonably estimated to be equal to the value of such benefits. |
(3) | This amount is payable according to normal payroll practices for one year following the NEO’s date of death. |
(4) | This amount is paid in a lump sum following the NEO’s date of termination. |
(5) | As Messrs. Cummings, Cama and Kalamaras each has, or would have, attained the normal retirement age under SERP II at, or within three years following, his date of termination, the amount for Messrs. Cummings, Cama and Kalamaras includes $3,254,465, $1,850,440 and $425,246, respectively, which represents the actuarial present value of the benefits that would have accrued under SERP II for three additional years of service following the date of termination. |
(6) | This amount is generally payable in a lump sum to the NEO following the date of termination, but it may be timely paid directly to the applicable taxing authorities on behalf of the NEO. |
Name and Address of Beneficial Owner |
Number of Shares Owned and Nature of Beneficial Ownership |
Percent of Shares of Common Stock Outstanding (1) |
||||||
BlackRock, Inc. 55 East 52nd Street New York, NY 10055 |
35,513,721 | (2) |
14.25 | % | ||||
The Vanguard Group 100 Vanguard Blvd. Malvern, PA 19355 |
24,613,281 | (3) |
9.88 | % | ||||
Fuller & Thaler Asset Management, Inc. 411 Borel Avenue, Suite 300 San Mateo, CA 94402 |
15,840,753 | (4) |
6.36 | % | ||||
Investors Bank Employee Stock Ownership Plan Trust Trustee: TI-Trust, Inc.2900 North 23rd Street Quincy, IL 62305 |
15,346,001 | (5) |
6.16 | % | ||||
Dimensional Fund Advisors LP 6300 Bee Cave Road, Building One Austin, TX 78746 |
11,717,989 | (6) |
4.70 | % |
(1) | Based on 249,038,728 shares of Investors Bancorp common stock outstanding as of March 22, 2022. |
(2) | Based on a Schedule 13G filed with the SEC on March 11, 2022 by BlackRock, Inc. |
(3) | Based on a Schedule 13G/A filed with the SEC on February 10, 2022 by The Vanguard Group. |
(4) | Based on a Schedule 13G/A filed with the SEC on February 8, 2022 by Fuller & Thaler Asset Management, Inc. |
(5) | Based on a Schedule 13G/A filed with the SEC on February 22, 2022 by Investors Bank Employee Stock Ownership Plan Trust. |
(6) | Based on a Schedule 13G/A filed with the SEC on February 8, 2022 by Dimensional Fund Advisors LP. |
Name |
Position(s) held with Investors Bancorp Inc. and/or Investors Bank |
Shares Owned Directly and Indirectly (1) |
Options Exercisable within 60 days |
Beneficial Ownership |
Percent of Class (2) |
Unvested Stock Awards Included in Beneficial Ownership |
||||||||||||||||
DIRECTORS |
||||||||||||||||||||||
Robert C. Albanese |
Director | 107,419 | — | 107,419 | * | — | ||||||||||||||||
Domenick A. Cama |
Director, President and Chief Operating Officer | 1,332,287 | 420,096 | 1,752,383 | * | 101,270 | ||||||||||||||||
James J. Garibaldi |
Director | 66,980 | — | 66,980 | * | — | ||||||||||||||||
James H. Ward III |
Director | 436,400 | — | 436,400 | * | — | ||||||||||||||||
Dennis M. Bone |
Lead Independent Director | 155,674 | — | 155,674 | * | — | ||||||||||||||||
Doreen R. Byrnes |
Director | 116,694 | — | 116,694 | * | — | ||||||||||||||||
William V. Cosgrove |
Director | 147,880 | — | 147,880 | * | — | ||||||||||||||||
Kevin Cummings |
Chairman and Chief Executive Officer |
1,731,793 | 525,120 | 2,256,913 | * | 126,588 | ||||||||||||||||
John E. Harmon, Sr. |
Director | 1,100 | — | 1,100 | * | — | ||||||||||||||||
Michele N. Siekerka |
Director | 172,699 | — | 172,699 | * | — | ||||||||||||||||
Paul N. Stathoulopoulos |
Director | 215,430 | — | 215,430 | * | — | ||||||||||||||||
Kim Wales |
Director | — | — | — | * | — | ||||||||||||||||
EXECUTIVE OFFICERS WHO ARE NOT DIRECTORS |
| |||||||||||||||||||||
Richard S. Spengler |
Senior Executive Vice President and Chief Lending Officer | 632,958 | 713,333 | 1,346,291 | * | 57,143 | ||||||||||||||||
Sean Burke |
Executive Vice President and Chief Financial Officer | 176,109 | 525,720 | 701,829 | * | 50,000 | ||||||||||||||||
Paul Kalamaras |
Senior Executive Vice President and Chief Risk Officer | 367,953 | 713,333 | 1,081,286 | * | 69,143 | ||||||||||||||||
All directors and executive officers as a group (15 persons) (2) |
5,661,376 | 2,897,602 | 8,558,978 | 3.44 | % | 404,144 |
* | Less than 1% |
(1) | Unless otherwise indicated, each person effectively exercises sole, or shared with spouse, voting and/or dispositive power as to the shares reported. |
(2) | Based on 249,038,728 shares of Investors Bancorp common stock outstanding as of March 22, 2022. |
(3) | Includes 185,372 shares of common stock allocated to the accounts of executive officers under the Investors Bank Employee Stock Ownership Plan (“ESOP”) and excludes the remaining 15,160,629 shares of common stock of which 10,347,370 are unallocated and held for the future benefit of all employee participants. Under the terms of the ESOP, shares of common stock allocated to the account of employees are voted in accordance with the instructions of the respective employees. Unallocated shares are voted by the ESOP Trustee in the same proportion as the vote obtained from participants on allocated shares. Includes 52,924 shares of common stock held through the Investors Bank 401(k) Plan (the “401(k) Plan”). |
(a)(3) | Exhibits |
31.1 |
31.2 |
INVESTORS BANCORP INC. | ||||||
Date: April 5, 2022 |
By: |
/s/ Kevin Cummings | ||||
Kevin Cummings | ||||||
Chairman and Chief Executive Officer |